Key details
Sponsor
Pirogov Russian National Research Medical University
Enrollment target
~90 participants
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 40 Years
Last updated December 2024